Filipinas - inglês - FDA (Food And Drug Administration)

marilz pharma'l corp - paracetamol - suspension - 250mg/5ml

Filipinas - inglês - FDA (Food And Drug Administration)

interhealthcare pharmaceuticals, inc.; distributor: marilz pharmaceuticals, inc. - omeprazole - capsule - 20 mg

Filipinas - inglês - FDA (Food And Drug Administration)

interhealthcare pharmaceuticals, inc.; distributor: marilz pharmaceutical - phenylpropanolamine hydrochloride , chlorphenamine maleate - syrup - 12.5 mg/1 mg per 5 ml

Filipinas - inglês - FDA (Food And Drug Administration)

interhealthcare pharmaceuticals, inc.; distributor: marilz pharmaceuticals - phenylpropanolamine hydrochloride , chlorphenamine maleate - syrup (oral drops) - 1.0mg/ 0.8mg per ml

Filipinas - inglês - FDA (Food And Drug Administration)

amb hk enterprises inc.; distributor: marilz pharmaceuticals, inc. - cefuroxime (as sodium) - powder for injection (im/iv) - 750mg

Austrália - inglês - APVMA (Australian Pesticides and Veterinary Medicines Authority)

submarino pty ltd - isoxaflutole - water dispersible granule - isoxaflutole ungrouped active 750.0 g /kg - herbicide

Austrália - inglês - APVMA (Australian Pesticides and Veterinary Medicines Authority)

submarino pty ltd - glyphosate present as the potassium salt - soluble concentrate - glyphosate present as the potassium salt glycine active 540.0 g/l - herbicide

Estados Unidos - inglês - NLM (National Library of Medicine)

abbvie inc. - dronabinol (unii: 7j8897w37s) (dronabinol - unii:7j8897w37s) - dronabinol 2.5 mg - marinol is indicated in adults for the treatment of: - anorexia associated with weight loss in patients with acquired immune deficiency syndrome (aids). - nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments. marinol is contraindicated in patients with a history of a hypersensitivity reaction to dronabinol or sesame oil. reported hypersensitivity reactions to dronabinol capsules include lip swelling, hives, disseminated rash, oral lesions, skin burning, flushing and throat tightness [see adverse reactions (6.2)] . marinol, a synthetic cannabinoid, may cause fetal harm. avoid use of marinol in pregnant women. although there is little published data on the use of synthetic cannabinoids during pregnancy, use of cannabis (e.g., marijuana) during pregnancy has been associated with adverse fetal/neonatal outcomes [see clinical considerations] . cannabinoids have been found in the umbilical cord blood from pregnant women who s

Estados Unidos - inglês - NLM (National Library of Medicine)

thepharmanetwork, llc - dronabinol (unii: 7j8897w37s) (dronabinol - unii:7j8897w37s) - marinol is indicated in adults for the treatment of: • anorexia associated with weight loss in patients with acquired immune deficiency syndrome (aids). • nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments. marinol® (dronabinol capsules, usp) is contraindicated in patients with a history of a hypersensitivity reaction to dronabinol or sesame oil. reported hypersensitivity reactions to dronabinol capsules include lip swelling, hives, disseminated rash, oral lesions, skin burning, flushing and throat tightness [see adverse reactions (6.2)] . risk summary marinol, a synthetic cannabinoid, may cause fetal harm. avoid use of marinol in pregnant women. although there is little published data on the use of synthetic cannabinoids during pregnancy, use of cannabis (e.g., marijuana) during pregnancy has been associated with adverse fetal/neonatal outcomes [see clinical considerations]. cannabinoids have been found

Estados Unidos - inglês - NLM (National Library of Medicine)

thepharmanetwork, llc - dronabinol (unii: 7j8897w37s) (dronabinol - unii:7j8897w37s) - marinol is indicated in adults for the treatment of: - anorexia associated with weight loss in patients with acquired immune deficiency syndrome (aids). - nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.  marinol® (dronabinol capsules, usp), is contraindicated in patients with a history of a hypersensitivity reaction to dronabinol or sesame oil. reported hypersensitivity reactions to dronabinol capsules include lip swelling, hives, disseminated rash, oral lesions, skin burning, flushing and throat tightness [see adverse reactions (6.2)].  risk summary marinol, a synthetic cannabinoid, may cause fetal harm. avoid use of marinol in pregnant women. although there is little published data on the use of synthetic cannabinoids during pregnancy, use of cannabis (e.g., marijuana) during pregnancy has been associated with adverse fetal/neonatal outcomes (see clinical considerations). cannabinoids have been found i